The newborn Fmr1 knockout mouse: a novel model of excess ubiquinone and closed mitochondrial permeability transition pore in the developing heart

Pediatr Res. 2021 Feb;89(3):456-463. doi: 10.1038/s41390-020-1064-6. Epub 2020 Jul 16.

Abstract

Background: Mitochondrial permeability transition pore (mPTP) closure triggers cardiomyocyte differentiation during development while pathological opening causes cell death during myocardial ischemia-reperfusion and heart failure. Ubiquinone modulates the mPTP; however, little is known about its mechanistic role in health and disease. We previously found excessive proton leak in newborn Fmr1 KO mouse forebrain caused by ubiquinone deficiency and increased open mPTP probability. Because of the physiological differences between the heart and brain during maturation, we hypothesized that developing Fmr1 KO cardiomyocyte mitochondria would demonstrate dissimilar features.

Methods: Newborn male Fmr1 KO mice and controls were assessed. Respiratory chain enzyme activity, ubiquinone content, proton leak, and oxygen consumption were measured in cardiomyocyte mitochondria. Cardiac function was evaluated via echocardiography.

Results: In contrast to controls, Fmr1 KO cardiomyocyte mitochondria demonstrated increased ubiquinone content and decreased proton leak. Leak was cyclosporine (CsA)-sensitive in controls and CsA-insensitive in Fmr1 KOs. There was no difference in absolute mitochondrial respiration or cardiac function between strains.

Conclusion: These findings establish the newborn Fmr1 KO mouse as a novel model of excess ubiquinone and closed mPTP in the developing heart. Such a model may help provide insight into the biology of cardiac development and pathophysiology of neonatal heart failure.

Impact: Ubiquinone is in excess and the mPTP is closed in the developing FXS heart. Strengthens evidence of open mPTP probability in the normally developing postnatal murine heart and provides new evidence for premature closure of the mPTP in Fmr1 mutants. Establishes a novel model of excess CoQ and a closed pore in the developing heart. Such a model will be a valuable tool used to better understand the role of ubiquinone and the mPTP in the neonatal heart in health and disease.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Atractyloside / analogs & derivatives
  • Atractyloside / pharmacology
  • Cyclosporine / pharmacology
  • Disease Models, Animal*
  • Electron Transport
  • Fetal Heart / metabolism*
  • Fragile X Mental Retardation Protein / genetics*
  • Fragile X Syndrome / genetics
  • Fragile X Syndrome / metabolism*
  • Guanosine Diphosphate / pharmacology
  • Male
  • Mice
  • Mice, Knockout*
  • Mitochondria, Heart / drug effects
  • Mitochondria, Heart / metabolism*
  • Mitochondrial Permeability Transition Pore*
  • Myocytes, Cardiac / metabolism
  • Oxygen Consumption
  • Proton-Motive Force
  • Single-Blind Method
  • Ubiquinone / analogs & derivatives
  • Ubiquinone / metabolism*
  • Ubiquinone / pharmacology

Substances

  • Fmr1 protein, mouse
  • Mitochondrial Permeability Transition Pore
  • Ubiquinone
  • Fragile X Mental Retardation Protein
  • Guanosine Diphosphate
  • Atractyloside
  • 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone
  • Cyclosporine
  • carboxyatractyloside